Rare Cancers
FY24 Idea Development Award
The list of Fiscal Year 2024 Rare Cancers Research Program Idea Development Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Children's Hospital Los Angeles | Liya Xu |
Cleveland Clinic Foundation | Jan Melenhorst |
Duke University | Corinne Linardic |
Flashpoint Therapeutics, Inc. | Adam Margolin |
Icahn School of Medicine at Mount Sinai | Alexander Tsankov |
Mayo Clinic and Foundation | Sumera Ilyas |
The University of Texas Health Science Center at Houston | Ali Azhdarinia |
The Broad Institute, Inc. | William Sellers |
University of California, San Francisco | Pavithra Viswanath |
University of Illinois Urbana-Champaign | Michael Spinella |
University of Minnesota Twin Cities | Darko Bosnakovski |
University of Washington | Eleanor Chen |
Last updated Tuesday, April 15, 2025